Use of VEGFR-3 inhibitors to treat hepatocellular carcinoma

摘要

A compound of formula (I), ** (See formula) ** in which R is a methoxy or hydroxyl group, or a pharmaceutically acceptable salt thereof, for use in the treatment of hepatocellular carcinoma.